| Patient severity group | Patients (N) | SOFA (points) | Length of stay (days) | 28-day mortality (N, %) | 90-day mortality (N, %) |
---|---|---|---|---|---|---|
Day 4 | Total patient population | 777 | 8.4 (4.3) | 16 (10–27) | 158 (20.3%) | 256 (33.9%) |
Clinically stable population | 145 | 4.5 (2.4) | 8 (6–11) | 10 (6.9%) | 22 (15.8%) | |
Clinically stable and low MR-proADM population | 79 | 3.6 (1.5) | 8 (7–10) | 0 (0.0%) | 1 (1.4%) | |
Actual day-4 discharges | 43 | 3.6 (2.1) | – | 1 (2.3%) | 4 (10.0%) | |
Day 7 | Total patient population | 630 | 8.0 (4.2) | 19 (13–31) | 127 (20.2%) | 214 (34.9%) |
Clinically stable population | 124 | 3.9 (1.7) | 11.5 (9–16) | 9 (7.3%) | 17 (13.9%) | |
Clinically stable and low MR-proADM population | 78 | 3.4 (1.6) | 11 (9–14) | 1 (1.3%) | 4 (5.3%) | |
Actual day-7 discharges | 36 | 3.6 (2.6) | – | 2 (5.6%) | 5 (13.9%) | |
Day 10 | Total patient population | 503 | 7.6 (4.0) | 23.5 (17–34.25) | 82 (16.3%) | 159 (32.6%) |
Clinically stable population | 85 | 3.5 (1.8) | 15 (13–22) | 9 (10.6%) | 14 (17.3%) | |
Clinically stable and low MR-proADM population | 57 | 3.2 (1.3) | 14 (12.25–19) | 1 (1.8%) | 2 (3.8%) | |
Actual day-10 discharges | 29 | 4.0 (2.6) | – | 5 (17.2%) | 7 (24.1%) |